Stock Weekly: Medicenna Therapeutics (MDNA:CAD5.48) tumbles 7.9% on firm volume
CANADIAN WEEKLY STOCK REPORT
Medicenna Therapeutics Corp. (TSX:MDNA), Canada's 13th largest Biotechnology company by market cap, has sunk 47.0c (or 7.9%) in the past week to close at CAD5.48. Compared with the S&P/TSX 60 Index which rose 38.2 points (or 3.7%) in the week, this represented a relative price change of -11.6%. The stock fell for a second week on Friday bringing its a two-week fall to 59.0c or 9.7%.
The price ranged between a low of CAD5.33 on Wednesday, Jan 06 and a hig...